Clinical Trial Update: RYZ101 for the Treatment of Progressive or Recurrent Intracranial Meningioma [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of RYZ101 for progressive or recurrent intracranial meningioma has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningioma

Drugs mentioned

• RYZ101

Snippet

Sponsor: Joshua Palmer | Conditions: Recurrent Meningioma | Phase 1, Phase 2 | Status: SUSPENDED